Search
for
Sort by
Research 211–240 of 226
- The 46th Annual Meeting of the Irish Endocrine Society Meeting Programme and Abstracts 2022
- Chemistry, Pharmacology and Therapeutic Potential of Decursin: A Promising Natural Lead for New Drug Discovery and Development
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Efficacy of Platelet-Rich Plasma versus 5% Topical Monixidil for the Treatment of Androgenetic Alopecia
- Cutaneous Adverse Drug Reactions to Antibiotics: How Much is the Extent of the Problem?
- Growth Factor Cocktail Including Fibroblast Growth Factor 9 (Cellcurin) in the Treatment of Androgenetic Alopecia in Men and Women: A Randomized Controlled Trial
- Current understanding and treatment of sex hormone-related hair diseases
- Deflúvio Telogénico Crónico
- Safety and Efficacy of Nutrition-Based Interventions for Hair
- Changes in bone mineral density in women with early-onset androgenetik alopecia and their correlations with hair-loss stages: a cross-sectional study
- Saw palmetto extract: A dermatologist's perspective
- Cyberspace Chat: Safe management of patients on Plavix® (clopidogrel) for hair restoration surgery (HRS)
- ZALCITABINE
- 69-Year-Old Man With Dysuria and Right Lower Abdominal Pain
- Serum Vitamin Levels in Different Categories of Androgenetic Alopecia Subjects
- Warfarin: almost 60 years old and still causing problems
- WARFARIN-INDUCED ALOPECIA: A RARE CASE REPORT
- WARFARIN
- Pseudoxanthoma Elasticum: Progress in Research Toward Treatment: Summary of the 2012 PXE International Research Meeting
- Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature
- Hypersensitivity Reactions to Anticoagulant Drugs
- Enoxaparin-induced alopecia in patients with cerebral venous thrombosis
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Anti-Alopecic Activity of a Novel Compound from Aloe barbadensis Miller
- E031 Retinal vasculitis with Libman-Sacks endocarditis as presenting features of a systemic lupus erythematosus with antiphospholipid antibody syndrome patient
- Culprits of Medication-Induced Telogen Effluvium, Part 2
- Drugs affecting blood coagulation, fibrinolysis, and hemostasis
- ANNOUNCEMENTS